Literature DB >> 33169943

NANDA-I, NOC, and NIC linkages to SARS-CoV-2 (COVID-19): Part 2. Individual response.

Elizabeth Swanson1, Vanessa Monteiro Mantovani2, Cheryl Wagner1, Sue Moorhead1, Karen Dunn Lopez1, Tamara Gonçalves Rezende Macieira3, Noriko Abe1.   

Abstract

PURPOSE: To provide guidance to nurses caring for individuals with COVID-19, we developed linkages using interoperable standardized nursing terminologies: NANDA International (NANDA-I) nursing diagnoses, Nursing Interventions Classification (NIC), and Nursing Outcomes Classification (NOC). We also identified potential new NANDA-I nursing diagnoses, NOC outcomes, and NIC interventions for future development related to nurses' role during a pandemic.
METHODS: Using a consensus process, seven nurse experts created the linkages for individuals during the COVID 19 pandemic using the following steps: (a) creating an initial list of potential nursing diagnoses, (b) selecting and categorizing outcomes that aligned with all components of each nursing diagnosis selected, and (c) identifying relevant nursing interventions.
FINDINGS: A total of 16 NANDA-I nursing diagnoses were identified as the foundation for the linkage work, organized in two dimensions, physiological and psychosocial. A total of 171 different NOC outcomes were identified to guide care based on the nursing diagnoses and 96 NIC interventions were identified as suggested interventions. A total of 13 proposed concepts were identified for potential future development across the three classifications.
CONCLUSIONS: The linkages of nursing diagnoses, outcomes, and interventions developed in this article provide a guide to enhance nursing practice and determine the effectiveness of nurses' contribution to patient outcomes for individuals at risk for or infected by COVID-19. IMPLICATIONS FOR NURSING PRACTICE: NANDA-I, NOC, and NIC linkages identified in this paper are an important example of the value of using standardized nursing terminologies to guide and document nursing care. When included in electronic health record databases and used widely, the data generated from the care plans can be used to create new knowledge about how to better improve outcomes for patients with COVID-19.
© 2020 NANDA International, Inc.

Entities:  

Keywords:  COVID-19; NANDA-I; NIC; NOC; individuals; standardized nursing terminology

Year:  2020        PMID: 33169943     DOI: 10.1111/2047-3095.12307

Source DB:  PubMed          Journal:  Int J Nurs Knowl        ISSN: 2047-3087            Impact factor:   1.222


  5 in total

Review 1.  Responses Presented by Adult Patients with COVID-19, Based on the Formulated Nursing Diagnoses: A Scoping Review.

Authors:  Vanessa Cortinhal; António Pereira; Sofia Correia; Sérgio Deodato
Journal:  Int J Environ Res Public Health       Date:  2022-05-23       Impact factor: 4.614

2.  Nursing interventions for patients with COVID-19: A medical record review and nursing interventions classification study.

Authors:  Elnaz Asghari; Mandy Archibald; Fariborz Roshangar
Journal:  Int J Nurs Knowl       Date:  2021-06-05       Impact factor: 1.150

3.  Nurse-sensitive indicators during COVID-19.

Authors:  Gaurdia Banister; Diane L Carroll; Kirsten Dickins; Jane Flanagan; Dorothy Jones; Sara E Looby; Jennifer E Cahill
Journal:  Int J Nurs Knowl       Date:  2022-05-17       Impact factor: 1.150

4.  NANDA International nursing diagnoses in the coping/stress tolerance domain and their linkages to Nursing Outcomes Classification outcomes and Nursing Interventions Classification interventions in the pre-hospital emergency care.

Authors:  César Pedro Sánchez-Almagro; José Manuel Romero-Sánchez; Melanie White-Ríos; Carlos Antonio González Del Pino; Olga Paloma-Castro
Journal:  J Adv Nurs       Date:  2022-05-04       Impact factor: 3.057

5.  NANDA-I, NOC, and NIC linkages to SARS-CoV-2 (COVID-19): Part 3. Family response.

Authors:  Cheryl Marie Wagner; Elizabeth A Swanson; Sue Moorhead; Vanessa Monteiro Mantovani; Karen Dunn-Lopez; Tamara G R Macieira; Noriko Abe; Susie Breitenstein
Journal:  Int J Nurs Knowl       Date:  2021-03-17       Impact factor: 1.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.